Mackay Shields LLC Eli Lilly & CO Transaction History

Mackay Shields LLC

$581 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $31.8 Million - $37.4 Million	-114,222 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $1.05 Million - $1.31 Million	-4,486 Reduced 3.78%	114,222 $32.7 Million
Q4 2021 Feb 04, 2022	SELL	$224.85 - $279.04 $607,095 - $753,408	-2,700 Reduced 2.22%	118,708 $32.8 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $876,871 - $1.08 Million	-3,957 Reduced 3.16%	121,408 $28.1 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $6.89 Million - $8.91 Million	-38,155 Reduced 23.33%	125,365 $28.8 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $4.49 Million - $5.81 Million	-27,320 Reduced 14.32%	163,520 $30.5 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $1.07 Million - $1.42 Million	-8,198 Reduced 4.12%	190,840 $32.2 Million
Q3 2020 Nov 04, 2020	BUY	$146.22 - $169.13 $2.44 Million - $2.82 Million	16,662 Added 9.14%	199,038 $29.5 Million
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $5.57 Million - $6.7 Million	-40,828 Reduced 18.29%	182,376 $29.9 Million
Q1 2020 May 08, 2020	BUY	$119.05 - $147.35 $8.49 Million - $10.5 Million	71,310 Added 46.95%	223,204 $31 Million
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $440,296 - $545,346	-4,118 Reduced 2.64%	151,894 $20 Million
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $2.6 Million - $2.83 Million	-24,331 Reduced 13.49%	156,012 $17.4 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $10 Million - $11.7 Million	-90,564 Reduced 33.43%	180,343 $20 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $2.35 Million - $2.76 Million	-21,102 Reduced 7.23%	270,907 $35.2 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $5.12 Million - $5.73 Million	48,327 Added 19.83%	292,009 $33.8 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $21.5 Million - $26.9 Million	-250,525 Reduced 50.69%	243,682 $26.2 Million
Q2 2018 Aug 06, 2018	SELL	$75.7 - $86.88 $5.67 Million - $6.51 Million	-74,942 Reduced 13.17%	494,207 $42.2 Million
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $42.2 Million - $49.9 Million	569,149 New	569,149 $44 Million

Others Institutions Holding LLY

# of Institutions

4,010

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.7 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.9 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.9 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Account